Cargando…

In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway

BACKGROUND: Deoxyhypusine synthase (DHS) catalyzes the first step in hypusine biosynthesis of eukaryotic initiation factor 5A (eIF-5A) in Plasmodium falciparum. Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwentke, Andreas, Krepstakies, Marcel, Mueller, Ann-Kristin, Hammerschmidt-Kamper, Christiane, Motaal, Basma A, Bernhard, Tina, Hauber, Joachim, Kaiser, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438091/
https://www.ncbi.nlm.nih.gov/pubmed/22694849
http://dx.doi.org/10.1186/1471-2180-12-107
_version_ 1782242865279139840
author Schwentke, Andreas
Krepstakies, Marcel
Mueller, Ann-Kristin
Hammerschmidt-Kamper, Christiane
Motaal, Basma A
Bernhard, Tina
Hauber, Joachim
Kaiser, Annette
author_facet Schwentke, Andreas
Krepstakies, Marcel
Mueller, Ann-Kristin
Hammerschmidt-Kamper, Christiane
Motaal, Basma A
Bernhard, Tina
Hauber, Joachim
Kaiser, Annette
author_sort Schwentke, Andreas
collection PubMed
description BACKGROUND: Deoxyhypusine synthase (DHS) catalyzes the first step in hypusine biosynthesis of eukaryotic initiation factor 5A (eIF-5A) in Plasmodium falciparum. Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease. CNI-1493 prevented infected mice from experimental cerebral malaria by decreasing the levels in hypusinated eIF-5A and serum TNF, implicating a link between cytokine signaling and the hypusine pathway. Therefore we addressed the question whether either DHS itself or eIF-5A is required for the outcome of severe malaria. In a first set of experiments we performed an in vitro knockdown of the plasmodial eIF-5A and DHS proteins by RNA interference (RNAi) in 293 T cells. Secondly, transfection of siRNA constructs into murine Plasmodium schizonts was performed which, in turn, were used for infection. RESULTS: 293 T cells treated with plasmodial DHS- and eIF-5A specific siRNAs or control siRNAs were analyzed by RT-PCR to determine endogenous dhs -and eIF-5A mRNA levels. The expressed DHS-shRNA and EIF-5A-shRNA clearly downregulated the corresponding transcript in these cells. Interestingly, mice infected with transgenic schizonts expressing either the eIF-5A or dhs shRNA showed an elevated parasitemia within the first two days post infection which then decreased intermittently. These results were obtained without drug selection. Blood samples, which were taken from the infected mice at day 5 post infection with either the expressed EIF-5A-shRNA or the DHS-shRNA were analyzed by RT-PCR and Western blot techniques, demonstrating the absence of either the hypusinated form of eIF-5A or DHS. CONCLUSIONS: Infection of NMRI mice with schizonts from the lethal P. berghei ANKA wildtype strain transgenic for plasmodial eIF-5A-specific shRNA or DHS-specific shRNA resulted in low parasitemia 2–9 days post infection before animals succumbed to hyperparasitemia similar to infections with the related but non-lethal phenotype P. berghei strain NK65. RT-PCR and Western blot experiments performed with blood from the transfected erythrocytic stages showed that both genes are important for the proliferation of the parasite. Moreover, these experiments clearly demonstrate that the hypusine pathway in Plasmodium is linked to human iNos induction.
format Online
Article
Text
id pubmed-3438091
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34380912012-09-11 In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway Schwentke, Andreas Krepstakies, Marcel Mueller, Ann-Kristin Hammerschmidt-Kamper, Christiane Motaal, Basma A Bernhard, Tina Hauber, Joachim Kaiser, Annette BMC Microbiol Research Article BACKGROUND: Deoxyhypusine synthase (DHS) catalyzes the first step in hypusine biosynthesis of eukaryotic initiation factor 5A (eIF-5A) in Plasmodium falciparum. Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease. CNI-1493 prevented infected mice from experimental cerebral malaria by decreasing the levels in hypusinated eIF-5A and serum TNF, implicating a link between cytokine signaling and the hypusine pathway. Therefore we addressed the question whether either DHS itself or eIF-5A is required for the outcome of severe malaria. In a first set of experiments we performed an in vitro knockdown of the plasmodial eIF-5A and DHS proteins by RNA interference (RNAi) in 293 T cells. Secondly, transfection of siRNA constructs into murine Plasmodium schizonts was performed which, in turn, were used for infection. RESULTS: 293 T cells treated with plasmodial DHS- and eIF-5A specific siRNAs or control siRNAs were analyzed by RT-PCR to determine endogenous dhs -and eIF-5A mRNA levels. The expressed DHS-shRNA and EIF-5A-shRNA clearly downregulated the corresponding transcript in these cells. Interestingly, mice infected with transgenic schizonts expressing either the eIF-5A or dhs shRNA showed an elevated parasitemia within the first two days post infection which then decreased intermittently. These results were obtained without drug selection. Blood samples, which were taken from the infected mice at day 5 post infection with either the expressed EIF-5A-shRNA or the DHS-shRNA were analyzed by RT-PCR and Western blot techniques, demonstrating the absence of either the hypusinated form of eIF-5A or DHS. CONCLUSIONS: Infection of NMRI mice with schizonts from the lethal P. berghei ANKA wildtype strain transgenic for plasmodial eIF-5A-specific shRNA or DHS-specific shRNA resulted in low parasitemia 2–9 days post infection before animals succumbed to hyperparasitemia similar to infections with the related but non-lethal phenotype P. berghei strain NK65. RT-PCR and Western blot experiments performed with blood from the transfected erythrocytic stages showed that both genes are important for the proliferation of the parasite. Moreover, these experiments clearly demonstrate that the hypusine pathway in Plasmodium is linked to human iNos induction. BioMed Central 2012-06-13 /pmc/articles/PMC3438091/ /pubmed/22694849 http://dx.doi.org/10.1186/1471-2180-12-107 Text en Copyright ©2012 Schwentke et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Schwentke, Andreas
Krepstakies, Marcel
Mueller, Ann-Kristin
Hammerschmidt-Kamper, Christiane
Motaal, Basma A
Bernhard, Tina
Hauber, Joachim
Kaiser, Annette
In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
title In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
title_full In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
title_fullStr In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
title_full_unstemmed In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
title_short In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway
title_sort in vitro and in vivo silencing of plasmodial dhs and eif-5a genes in a putative, non-canonical rnai-related pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438091/
https://www.ncbi.nlm.nih.gov/pubmed/22694849
http://dx.doi.org/10.1186/1471-2180-12-107
work_keys_str_mv AT schwentkeandreas invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT krepstakiesmarcel invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT muellerannkristin invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT hammerschmidtkamperchristiane invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT motaalbasmaa invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT bernhardtina invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT hauberjoachim invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway
AT kaiserannette invitroandinvivosilencingofplasmodialdhsandeif5agenesinaputativenoncanonicalrnairelatedpathway